$INAB
IN8bio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INAB up today? It is at $1.28 (+5.79%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INAB spikes, and full due diligence on INAB — key stats, earnings, dilution and insider activity. Free.
Get free $INAB alerts the moment volume spikes
Our scanner flagged $INAB 1 time in the last 30 days. Create a free account to track $INAB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1.28
- Change today
- +5.79%
- Previous close
- $1.21
- 52-week range
- $0.880 – $2.73
- Market cap
- $13M
- Shares outstanding
- 9.9M SEC · as of 2026-08-03 · 20d
- Institutional own.
- 38.85%
- Total held
- 38.9%
- Tradeable float
- 6.0M 61% of shares · after <1% insiders + 39% institutions
- Short interest
- 25K ▲ +20% vs prior · as of 2026-07-31
- Short % of float
- 0.4%
- Days to cover
- 1.0d
- Avg daily volume
- 117K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 390x
- 15mthin
- 7195x
- 1hthin
- 7195x
- 1D
- --
Get free INAB + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $INAB up today?
Here is the latest on INAB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INAB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Analyst data via Nasdaq. Not investment advice.
Insiders
0 buys, 1 sells last 3 months (6/1 over 12 months)Show 7 recent transactionsMinimize 7 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Fairbairn Emily Director | Sold (automatic/other) | -725K 7.4% of company | sold 99% | 4K | n/a | May 27, 26 |
Fairbairn Emily Director | Acquired (grant/award) | +725K 7.4% of company | added 100% | 729K | $1000K at $1.38 | Dec 22, 25 |
Roemer Alan S. Director | Acquired (grant/award) | +36K 0.4% of company | added 100% | 50K | $50K at $1.38 | Dec 22, 25 |
Brandt Peter C. Director | Acquired (grant/award) | +72K 0.7% of company | added 100% | 95K | $100K at $1.38 | Dec 22, 25 |
Rochlin Kate Officer | Acquired (grant/award) | +7K 0.07% of company | added 100% | 9K | $10K at $1.38 | Dec 22, 25 |
Ho William Tai-Wei Officer | Acquired (grant/award) | +36K 0.4% of company | added 43% | 121K | $50K at $1.38 | Dec 22, 25 |
Mccall Patrick Officer | Acquired (grant/award) | +7K 0.07% of company | added 100% | 9K | $10K at $1.38 | Dec 22, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $INAB runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 1,497,326 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $2.8M in size · Priced at $1.87/share
- At-the-market (ATM) program — sells new shares into the market gradually over time · Baby-shelf capped: no more than one third of public float in any 12 months
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$INAB Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$INAB Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to INAB
Comparable names in biological products, (no diagnostic substances), closest in size first.
INAB stock FAQ
Why is $INAB up today?
Here is the latest on INAB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INAB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the INAB stock price today?
INAB last traded at $1.28, up 5.79% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live INAB alerts?
The INAB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INAB 1 time in the last 30 days.
What exchange is INAB on?
INAB (IN8bio, Inc. Common Stock) trades on XNAS, with a market cap of about $13M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is INAB good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INAB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.